Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Loncar Cancer Immunotherapy ETF (NQ: CNCR )

11.32 +0.31 (+2.86%)
Official Closing Price Updated: 4:15 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Loncar Cancer Immunotherapy ETF

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. 
Via InvestorPlace
5 Top-Ranked ETFs To Buy At Bargain Prices For 2023
Here are five ETFs from different zones that have plunged the most over the past year but are poised to outperform when the market resumes its uptrend. 
Via Talk Markets
5 ETFs Riding High On The Biotech Comeback
The high-growth biotech segment has borne the maximum brunt of the broader market sell-off. 
Via Talk Markets
3 Promising Oncology Stocks To Consider Adding To Your Portfolio
With tech integration and DNA sequencing increasing the efficacy of potential cancer drugs in the pipeline, we believe biotech names AstraZeneca, Amgen and Incyte are worth adding to a portfolio. 
Via Talk Markets
Best Biotech Stocks & ETFs for mRNA, Gene Editing
2020 was the most challenging year in decades but it was great for scientific innovation, particularly in the biotech space. 
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.